Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Redox generation of nitric oxide to radiosensitize hypoxic cells.

Mitchell JB, DeGraff W, Kim S, Cook JA, Gamson J, Christodoulou D, Feelisch M, Wink DA.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):795-8.

PMID:
9845098
2.

The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO.

Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, Mitchell JB.

Arch Biochem Biophys. 1998 Mar 1;351(1):66-74.

PMID:
9501920
3.

Hypoxic mammalian cell radiosensitization by nitric oxide.

Mitchell JB, Wink DA, DeGraff W, Gamson J, Keefer LK, Krishna MC.

Cancer Res. 1993 Dec 15;53(24):5845-8.

PMID:
8261391
4.

Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.

Krishna MC, DeGraff W, Tamura S, Gonzalez FJ, Samuni A, Russo A, Mitchell JB.

Cancer Res. 1991 Dec 15;51(24):6622-8.

5.

Radiosensitization of hypoxic tumor cells in vitro by nitric oxide.

Griffin RJ, Makepeace CM, Hur WJ, Song CW.

Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):377-83.

PMID:
8892463
6.

Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.

Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A.

Arch Biochem Biophys. 1991 Aug 15;289(1):62-70.

PMID:
1654848
7.

Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.

Samuni Y, Wink DA, Krishna MC, Mitchell JB, Goldstein S.

Free Radic Biol Med. 2014 Aug;73:291-8. doi: 10.1016/j.freeradbiomed.2014.05.019. Epub 2014 May 28.

PMID:
24880052
8.

Radiation sensitisation by nitric oxide releasing agents.

Mitchell JB, Cook JA, Krishna MC, DeGraff W, Gamson J, Fisher J, Christodoulou D, Wink DA.

Br J Cancer Suppl. 1996 Jul;27:S181-4.

9.
10.

Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.

De Ridder M, Van Esch G, Engels B, Verovski V, Storme G.

Bull Cancer. 2008 Mar;95(3):282-91. doi: 10.1684/bdc.2008.0592. Review.

PMID:
18390408
11.

Nitroxyl anion regulation of the NMDA receptor.

Colton CA, Gbadegesin M, Wink DA, Miranda KM, Espey MG, Vicini S.

J Neurochem. 2001 Sep;78(5):1126-34.

12.

Effect of nitroxyl on the hamster retinal nitridergic pathway.

Sáenz DA, Bari SE, Salido E, Chianelli M, Rosenstein RE.

Neurochem Int. 2007 Nov-Dec;51(6-7):424-32. Epub 2007 May 3.

PMID:
17543420
13.

Induction of DNA strand breakage and base oxidation by nitroxyl anion through hydroxyl radical production.

Ohshima H, Gilibert I, Bianchini F.

Free Radic Biol Med. 1999 May;26(9-10):1305-13.

PMID:
10381204
14.
15.

Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.

Papadopoulou MV, Ji M, Khan SH, Bloomer WD.

Oncol Res. 1999;11(8):345-57.

PMID:
10803738
16.

Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation.

Janssens MY, Verovski VN, Van den Berge DL, Monsaert C, Storme GA.

Br J Cancer. 1999 Mar;79(7-8):1085-9.

17.
19.

The effect of ploidy on the modification of the shoulder region of hypoxic cell-survival curves by the biradical, Ro.03-6061.

Millar BC, Millar JL.

Int J Radiat Biol Relat Stud Phys Chem Med. 1977 Apr;31(4):355-63.

PMID:
301125
20.

Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.

Papadopoulou MV, Bloomer WD.

Anticancer Drugs. 2009 Jul;20(6):493-502. doi: 10.1097/CAD.0b013e32832cad9b.

PMID:
19430289
Items per page

Supplemental Content

Write to the Help Desk